Chromadex Corp (CDXC) Annual Income Statement (USD)
CDXC Quarterly Financials (USD)
Frequently Asked Questions About Chromadex Corp (CDXC) Stock
Chromadex Corp's (CDXC) last reported annual revenue was USD 83.57 Million.
Chromadex Corp's (CDXC) annual revenue growth rate based on the revenue reported in the past 5 years is : 21.50%
Chromadex Corp's(CDXC) is not profitable as of its last reported annual financials.
The net profit margin for Chromadex Corp's(CDXC) from its laster reported year is -5.91%
The return on equity (ROE) for Chromadex Corp's(CDXC) from its last reported annual financials is : -17.29%
The return on assets (ROA) for Chromadex Corp's(CDXC) from its last reported annual financials is : -6.42%
The return on invested capital (ROIC) for Chromadex Corp's(CDXC) from its last reported annual financials is : -6.65%
The Debt to Equity ratio for Chromadex Corp's(CDXC) from its last reported annual financials is : 0.00%
The dividend yield for Chromadex Corp's(CDXC) from its laster reported year is 0.00%
Chromadex Corp's(CDXC) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CDXC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
